SCHEMBL2842931

SCHEMBL2842931

c1ccc(Nc2ccc(N(c3ccc(Nc4ccccc4)cc3)c3ccc(Nc4ccccc4)cc3)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.68
HSD17B10 Q99714 5/20 0.68
L3MBTL1 Q9Y468 5/20 0.68
TDP1 Q9NUW8 5/20 0.68
ALOX12 P18054 4/20 0.68
TSHR P16473 4/20 0.68
ALOX15 P16050 2/20 0.68
PTGS1 P23219 1/20 0.68
SLC6A2 P23975 1/20 0.68
MAPK1 P28482 1/20 0.68
PTGS2 P35354 1/20 0.68
HTR2B P41595 1/20 0.68
MAPT P10636 8/20 0.54
CYP3A4 P08684 6/20 0.54
HPGD P15428 4/20 0.54
HTT P42858 2/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2C9 P11712 2/20 0.54
CYP2C19 P33261 2/20 0.54
MEN1 O00255 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16380999 1.00 ALDH1A1 (0.68) ALDH1A1HSD17B10L3MBTL1TDP1ALOX12
SCHEMBL18135005 1.00 ALDH1A1 (0.68) ALDH1A1HSD17B10L3MBTL1TDP1ALOX12
SCHEMBL15730724 0.97 ALDH1A1 (0.65) ALDH1A1HSD17B10L3MBTL1TDP1ALOX12
SCHEMBL11961727 0.97 ALDH1A1 (0.65) ALDH1A1HSD17B10L3MBTL1TDP1ALOX12
SCHEMBL273403 0.97 ALDH1A1 (0.65) ALDH1A1HSD17B10L3MBTL1TDP1ALOX12
SCHEMBL20684708 0.97 ALDH1A1 (0.65) ALDH1A1HSD17B10L3MBTL1TDP1ALOX12
SCHEMBL21368526 0.95 ALDH1A1 (0.60) ALDH1A1HSD17B10L3MBTL1TDP1ALOX12
SCHEMBL13148780 0.95 ALDH1A1 (0.60) ALDH1A1HSD17B10L3MBTL1TDP1ALOX12
SCHEMBL17703878 0.95 ALDH1A1 (0.60) ALDH1A1HSD17B10L3MBTL1TDP1ALOX12
SCHEMBL16168638 0.95 ALDH1A1 (0.60) ALDH1A1HSD17B10L3MBTL1TDP1ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9755165-B2 Silsesquioxane compound, organic light emitting element, display apparatus, image information processing apparatus, and image forming apparatus CANON KABUSHIKI KAISHA (JP) 2017-09-05 US disclosed
US-20160118607-A1 SILSESQUIOXANE COMPOUND, ORGANIC LIGHT EMITTING ELEMENT, DISPLAY APPARATUS, IMAGE INFORMATION PROCESSING APPARATUS, AND IMAGE FORMING APPARATUS CANON KABUSHIKI KAISHA (JP) 2016-04-28 US disclosed
WO-2014163028-A1 SILSESQUIOXANE COMPOUND, ORGANIC LIGHT EMITTING ELEMENT, DISPLAY APPARATUS, IMAGE INFORMATION PROCESSING APPARATUS, AND IMAGE FORMING APPARATUS CANON KABUSHIKI KAISHA (JP) 2014-10-09 WO disclosed
US-20100130786-A1 METHOD FOR PRODUCING TRIARYLAMINE COMPOUND HODOGAYA CHEMICAL CO., LTD. (JP) 2010-05-27 US disclosed
EP-2157077-A1 METHOD FOR PRODUCING TRIARYLAMINE COMPOUND Hodogaya Chemical Co., Ltd. (JP) 2010-02-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130786-A1 METHOD FOR PRODUCING TRIARYLAMINE COMPOUND NAT1, AADAC, DDT ALDH1A1 482/4885HSD17B10 255/4885L3MBTL1 2461/4885
US-20160118607-A1 SILSESQUIOXANE COMPOUND, ORGANIC LIGHT EMITTING ELEMENT, DISPLAY APPARATUS, IMAGE INFORMATION PROCESSING APPARATUS, AND IMAGE FORMING APPARATUS SFXN1, LSS, SLC7A5 ALDH1A1 1716/4885HSD17B10 3403/4885L3MBTL1 3632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.